Early Detection Research Network

CRYBG1

Aliases:
This biomarker is also known as:
  • Beta/Gamma Crystallin Domain-Containing Protein 1,
  • Suppression Of Tumorigenicity 4 (Malignant Melanoma),
  • Crystallin Beta-Gamma Domain Containing 1,
  • Suppression Of Tumorigenicity 4,
  • AIM1,
  • Absent In Melanoma 1,
  • Beta-Gamma Crystallin Domain Containing 1,
  • ST4,
  • CRYBG1,
  • AIM,
  • Absent In Melanoma 1 Protein,

Description…

AIM1 may function as suppressor of malignant melanoma. It is also thought to exert its effects through interactions with the cytoskeleton.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Under Review
Type: Protein
HGNC Name: CRYBG1

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.